Approval · Notice of Compliance 13541 · 2012
SANDOZ FENOFIBRATE E: Notice of Compliance 13541
Issued August 2, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13541
- Date
- August 2, 2012
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Lipid Metaboliism Regulator
- Canadian reference product
- LIPIDIL EZ (Fournier Pharma Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SANDOZ FENOFIBRATE E | 02390698 | Marketed |
| SANDOZ FENOFIBRATE E | 02390701 | Marketed |
Medicinal ingredients
- FENOFIBRATE 48 MG per TAB
- FENOFIBRATE 145 MG per TAB